Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

9 Dec 2010 07:00

RNS Number : 6098X
PZ CUSSONS PLC
09 December 2010
 



9 December 2010

 

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2010.

 

First half trading

 

PZ Cussons is pleased to confirm that results for the first half of the financial year have been in line with management expectations, with profitability marginally ahead of the same period last year on broadly flat revenue. The financial position of the Group remains strong with cash generation during the period also in line with expectations, and with the Group remaining in a net funds position at the end of the period.

 

Trading - Overview

 

Performance by individual region is as follows:

 

·; Lower profitability in Europe reflecting both a strong comparative period which included both high Carex sales in the UK following the swine flu outbreak and high export sales in Poland, together with the full effect of the Greek economic crisis now impacting performance;

·; Higher profitability in Asia as a result of continued positive momentum across all Asian territories;

·; Broadly flat performance in Africa as a result of liquidity provision in the market remaining tight during the first half coupled with uncertainty ahead of the Nigerian presidential elections scheduled for Spring 2011.

 

Trading - Regional Performance

 

Europe

 

In the UK, the trading environment remains very competitive with high levels of promotional activity continuing particularly on shower gel and handwash products. Nevertheless, new product launches across all brands have been well received, with the more premium brands The Sanctuary and the recently acquired St Tropez performing particularly well.

 

As announced on 27 September 2010, the Group acquired the entire issued share capital of St Tropez Holdings Limited for £62.5m in cash. The acquisition further strengthens the Group's portfolio of 'masstige' brands which includes The Sanctuary and Charles Worthington. The business has performed well post acquisition and plans to finalise the future operational structure of the business are well advanced.

 

 

Performance in Poland has been good albeit with lower export sales than the prior year. The economic environment in Greece is resulting in challenging trading conditions with sales and profitability lower than the same period last year.

 

Asia

 

Performance in Australia, Indonesia and the Middle East has been strong with continued positive momentum behind the brands in those territories.

 

Africa

 

In Nigeria, liquidity provision in the market has remained tight during the first half of the current year resulting in a broadly flat performance versus the comparative period. Uncertainty continues around the timing of the presidential elections and whilst consumer expenditure has begun to improve towards the end of the first half, the risk of disruption to trading from the election process remains during the second half of the financial year.

 

Exceptional Items

 

Exceptional items at the half year will include transaction costs associated with the acquisition of St Tropez. At the full year these will include further costs associated with the restructuring of the business.

 

An exceptional charge in the full year will occur in relation to the enhanced transfer value exercise planned in the second half in relation to one of the closed UK based final salary pension schemes.

 

Full year outlook

 

We remain cautious about the trading environment for the remainder of the year, given continued high levels of promotional activity, particularly in the UK; a challenging outlook for the consumer in a number of markets; global increases in a number of commodity costs; and potential disruption to trading from the Nigerian election process.

 

Against this backdrop, our focus remains on driving profitable growth through continued brand renovation and margin improvement in all territories.

 

The outlook for the year therefore remains in line with expectations.

 

 

Interim Announcement

 

Interim results for the half year to 30 November 2010 will be announced on Tuesday 25th January 2011.

 

An analysts' presentation will be given at 9:30am on that day at the offices of Panmure Gordon, Moorgate Hall, 155 Moorgate, London EC2M 6XB.

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1016

Brandon Leigh - Finance Director

 

MHP Communications (Formerly Hogarth) Tel: 020 3128 8100

John Olsen / James White

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGAGPUPUGCR
Date   Source Headline
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.